Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes of Stockholders??? Equity (Deficit) (Unaudited)

v3.24.3
Condensed Consolidated Statements of Changes of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2022   1,312,521      
Beginning Balance at Dec. 31, 2022 $ 27,819 $ 131 $ 68,132,790 $ 0 $ (68,105,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment 0        
Stock-based compensation 3,995,020   3,995,020    
Vesting of RSUs (in shares)   8,997      
Vesting of RSUs 0 $ 1 (1)    
Exercise of warrants (in shares)   4,603      
Exercise of warrants 338,055   338,055    
Conversion of convertible secured debentures 0        
Settlement of liquidated damages (in shares)   52,502      
Settlement of liquidated damages 3,685,629 $ 5 3,685,624    
Exercise of stock options (in shares)   6,329      
Exercise of stock options 421,175 $ 1 421,174    
Net loss (11,144,012)       (11,144,012)
Ending Balance (in shares) at Sep. 30, 2023   1,384,952      
Ending Balance at Sep. 30, 2023 (2,676,314) $ 138 76,572,662 0 (79,249,114)
Beginning Balance (in shares) at Jun. 30, 2023   1,330,396      
Beginning Balance at Jun. 30, 2023 10,320,255 $ 133 71,890,449 0 (61,570,327)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment 0        
Stock-based compensation 917,993   917,993    
Vesting of RSUs (in shares)   703      
Settlement of liquidated damages (in shares)   52,502      
Settlement of liquidated damages 3,685,629 $ 5 3,685,624    
Exercise of stock options (in shares)   1,351      
Exercise of stock options 78,596   78,596    
Net loss (17,678,787)       (17,678,787)
Ending Balance (in shares) at Sep. 30, 2023   1,384,952      
Ending Balance at Sep. 30, 2023 (2,676,314) $ 138 76,572,662 0 (79,249,114)
Beginning Balance (in shares) at Dec. 31, 2023   1,389,884      
Beginning Balance at Dec. 31, 2023 (41,786,850) $ 139 77,004,714 0 (118,791,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment (26,983)     (26,983)  
Stock-based compensation 1,872,504   1,872,504    
Reverse stock split round up (in shares)   133,975      
Reverse stock split round up 0 $ 13 (13)    
Vesting of RSUs (in shares)   99,294      
Vesting of RSUs 0 $ 10 (10)    
Exercise of warrants (in shares)   653,819      
Exercise of warrants 4,635,257 $ 65 4,635,192    
Conversion of convertible secured debentures (in shares)   1,951,546      
Conversion of convertible secured debentures 5,758,926 $ 195 5,758,731    
At the Market (ATM) share offering (in shares)   1,406,424      
At the Market (ATM) share offering 9,357,954 $ 141 9,357,813    
Net loss (16,316,664)       (16,316,664)
Ending Balance (in shares) at Sep. 30, 2024   5,634,942      
Ending Balance at Sep. 30, 2024 (36,505,856) $ 563 98,628,931 (26,983) (135,108,367)
Beginning Balance (in shares) at Jun. 30, 2024   4,131,426      
Beginning Balance at Jun. 30, 2024 (29,360,078) $ 413 94,390,920 0 (123,751,411)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment (26,983)     (26,983)  
Stock-based compensation 532,539   532,539    
Reverse stock split round up (in shares)   133,975      
Reverse stock split round up 0 $ 13 (13)    
Vesting of RSUs (in shares)   8,707      
Vesting of RSUs 0 $ 1 (1)    
Exercise of warrants (in shares)   38,230      
Exercise of warrants 184,094 $ 4 184,090    
Conversion of convertible secured debentures (in shares)   1,322,604      
Conversion of convertible secured debentures 3,521,528 $ 132 3,521,396    
Net loss (11,356,956)       (11,356,956)
Ending Balance (in shares) at Sep. 30, 2024   5,634,942      
Ending Balance at Sep. 30, 2024 $ (36,505,856) $ 563 $ 98,628,931 $ (26,983) $ (135,108,367)